Wednesday, November 26, 2025

Wednesday, November 26, 2025

Organization Directory

Refine Your Search 5

Type:

Filter by Org Type:

Filter By Name:


Trending

  1. 1 UROVANT SCIENCES: Announces U.S. FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)
FDA Health News